Researchers have developed a way to predict how lung cancer cells will respond to different therapies, allowing people with the most common form of lung cancer to receive more effective individualized ...

A comparative evaluation of Quantum Support Vector Machines demonstrates an eight percent average recall gain over classical ...

Patients with lung cancer enrolling to Lung-MAP can now be matched to a targeted treatment trial based on prior genomic testing, without submitting new tumor or blood samples, making Lung-MAP ...

Newswise — Researchers have developed a way to predict how lung cancer cells will respond to different therapies, allowing people with the most common form of lung cancer to receive more effective ...

What is field carcinogenesis and how does it apply to lung cancer? Two experts offer a primer on this up-and-coming area in cancer research, and highlight some of the groundwork that is being laid for ...

A pilot trial suggests 4DCT-ventilation could help assess surgical candidates with early-stage lung cancer, particularly ...

ROS1 fusion-positive is a relatively rare driver gene abnormality found in approximately 1-2% of all non-small cell lung cancers. Domestic guidelines also state it is about 2%.Although the frequency ...